Big Four & Leading Accounting and Consulting Firms – news, opinion and career opportunities for aspiring & current professionals & alumni

PwC: Regulatory analysis capability added to Health Research Institute

By Rob Starr, Content Manager, Big4.com

PwC US today announced the expansion of its health industry research arm to include a new team focused on healthcare policy and regulatory issues.  The team, which joins PwC’s Health Research Institute (HRI), tracks and analyzes legislative and regulatory issues across the U.S. health landscape, delivering timely business insights to help executive decision makers navigate rapid change.

Based in Washington, DC, the regulatory team issues a weekly report and periodic in-depth examinations of major legislative and regulatory developments, providing analysis on the implications for organizations across the health spectrum, including insurers, providers, pharmaceutical and medical device companies, as well as employers and consumers.

PwC’s Health Research Institute publishes in-depth, data-driven reports and briefs on current and emerging health industry trends.  Recently published reports include: an analysis on the impact of the 2012 Presidential elections and the 113th U.S. Congress, an in-depth look at the demographic profile of the 30 million newly-insured population under the Affordable Care Act and new patients under the law’s Medicaid expansion.

PwC’s new HRI regulatory team includes: Bobby Clark, Matt DoBias and Caitlin Sweany, and is overseen by Benjamin Isgur, a director and former legislative director for the Texas House of Representatives.  HRI is led by managing director Ceci Connolly, a veteran Washington journalist and author.

Comments are closed.